Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.23.3
Document and Entity Information
 9 Months Ended
Sep. 30, 2023
Cover [Abstract]  
Entity Registrant Name SYROS PHARMACEUTICALS, INC.
Trading Symbol SYRS
Entity Central Index Key 0001556263
Document Type 10-Q
Document Period End Date Sep. 30, 2023
Amendment Flag false
Current Fiscal Year End Date --12-31
Entity Filer Category Non-accelerated Filer
Document Fiscal Year Focus 2023
Document Fiscal Period Focus Q3
Entity Small Business true
Entity Emerging Growth Company false
Entity Current Reporting Status Yes
Entity Shell Company false
Entity File Number 001-37813
Entity Tax Identification Number 45-3772460
Entity Address, Address Line One 35 CambridgePark Drive
Entity Address, Address Line Two 4th Floor
Entity Address, City or Town Cambridge
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02140
City Area Code 617
Local Phone Number 744-1340
Document Quarterly Report true
Document Transition Report false
Entity Interactive Data Current Yes
Entity Incorporation, State or Country Code DE
Title of 12(b) Security Common Stock, $0.001 par value
Security Exchange Name NASDAQ